Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, disabling side effect in non-small cell lung cancer (NSCLC) patients treated with platinum-based therapy. There is increasing evidence for associations between genetic variants and susceptibility to CIPN. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Corine, Herder, Gerarda J. M., van Haarlem, Simone W. A., van der Meer, Femke S., van Lindert, Anne S. R., ten Heuvel, Alexandra, Brouwer, Jan, Egberts, Toine C. G., Deneer, Vera H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858836/
https://www.ncbi.nlm.nih.gov/pubmed/36672910
http://dx.doi.org/10.3390/genes14010170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858836/
https://www.ncbi.nlm.nih.gov/pubmed/36672910
http://dx.doi.org/10.3390/genes14010170

Ejemplares similares